Christopher R. Lynch
Known title: DirectorCIK: 0002003622
Christopher R. Lynch's purchase track record
Christopher R. Lynch has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/28/2023 | NBBK | $2K | -0.8% | +7.2% | +14.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NBBK | ▼ Sell | Tax Withholding | 4,150 | $82K | 4/24/2026 | View on chart |
| NBBK | ▲ Buy | Grant | 7,685 | $0 | 1/2/2026 | View on chart |
| NBBK | ▼ Sell | Gift | 2,725 | $0 | 11/10/2025 | View on chart |
| NBBK | ▼ Sell | Gift | 600 | $0 | 10/30/2025 | View on chart |
| NBBK | ▼ Sell | Gift | 600 | $0 | 9/16/2025 | View on chart |
| NBBK | ▼ Sell | Gift | 600 | $0 | 9/10/2025 | View on chart |
| NBBK | ▼ Sell | Gift | 600 | $0 | 9/9/2025 | View on chart |
| NBBK | ▲ Buy | Grant | 75,237 | $0 | 4/24/2025 | View on chart |
| NBBK | ▲ Buy | Open Market | 100 | $1K | 12/28/2023 | View on chart |
| NBBK | ▲ Buy | Open Market | 25 | $348 | 12/28/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
NB Bancorp Reports Q3 Earnings Beat Estimates
NB Bancorp posted Q3 adjusted earnings of $0.60 per share, slightly above the $0.58 estimate, while sales of $76.545 million fell short of the $77.302 million forecast. Analysts note the company may still have room to move higher, though recent commentary suggests limited upside. The stock trades near its 52‑week high and sits above a key support level at $22.11.
NB Bancorp Reports Q3 Earnings Beat Estimates. NB Bancorp posted Q3 adjusted earnings of $0.60 per share, slightly above the $0.58 estimate, while sales of $76.545 million fell short of the $77.302 million forecast. Analysts note the company may still have room to move higher, though recent commentary suggests limited upside. The stock trades near its 52‑week high and sits above a key support level at $22.11.